Gordon Gary B.
SEC CIK 1811354 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TLSI | TriSalus Life Sciences, Inc. | Dir | 72.5K | $64.6K | — | 3 | 2026-02-23 | 2026-05-15 |
Most active insiders at TLSI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Stansky Michael P | Dir | $3.01M | — |
| 2 | Szela Mary T | CEO, Pres, Dir | $227.8K | $79.4K |
| 3 | Wahlstrom Mats | Dir | $151.8K | — |
| 4 | Valle William | Dir | $125.0K | — |
| 5 | Gordon Gary B. | Dir | $64.6K | — |
| 6 | Patience David | CFO | $32.2K | — |
| 7 | Marshak Richard | Chief Commercial Off | — | $15.7K |
| 8 | Stevens Jennifer | Chief Regulatory Off | — | $14.5K |
| 9 | Devlin Jodi | Chief of Clinical Ops | — | $13.2K |
| 10 | Cox Bryan F. | Chief of Research | — | $13.1K |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-18 16:42 | 2026-05-15 | TLSI | TriSalus Life Sciences, Inc. | Gordon Gary B. | Dir | P - Purchase | $2.46 | +10.0K | 72.5K | +16% | +$24.6K | |
| DM | 2026-05-15 16:39 | 2026-05-14 | TLSI | TriSalus Life Sciences, Inc. | Gordon Gary B. | Dir | A - Grant | $0.00 | +52.8K | 62.5K | +541% | $0 |
| 2026-02-23 | 2026-02-23 | TLSI | TriSalus Life Sciences, Inc. | Gordon Gary B. | Dir | P - Purchase | $4.10 | +9,756 | 9,756 | New | +$40.0K |
Purchase Sale Sale after option exercise All abbreviations